Remove our-products patient-engagement-platform
article thumbnail

5 best practices for improving patient engagement

pharmaphorum

Life science companies invest a significant number of resources to engage physicians and patient advocates. However, companies often fall short when it comes to engaging patients in a meaningful way during the product development process. Real-world examples of patient engagement success. Last Name *.

98
article thumbnail

Bayer Pharmaceuticals accelerates innovations for patients

LifeProNow

March 24,2023: “At its annual Pharma Media Day 2023, Bayer presented the latest progress in the ongoing transformation of its pharmaceutical business focusing on accelerating innovative healthcare solutions for the benefits of patients and delivering long-term, sustainable business growth. EU, Japan, and China.

Bioethics 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NK cell immunotherapy: what’s next in clinical development?

European Pharmaceutical Review

Yannis Morel, Executive Vice President of product portfolio strategy and business development of Innate Pharma SA, offers insight on engineering antibodies to develop antibody-based NK cell therapeutics. Two are already in Phase I and we have our first proprietary ANKET ® called IPH6501 hitting the clinic at the end of this year.

Immunity 111
article thumbnail

Plus Therapeutics and PPS expand partnership for cGMP drug production

Pharmaceutical Technology

Plus Therapeutics has expanded its partnership with Piramal Pharma Solutions (PPS) to produce additional cGMP liposome intermediate drug products. Plus Therapeutics is engaged in the development of targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers.

52
article thumbnail

How digital is transforming the commercial leader’s role in biopharma

pharmaphorum

Pharma’s evolving role in patient care. Pharma’s digital initiatives now routinely enable new channels that educate and market to patients, physician engagement that is more efficient and effective, and novel payment mechanisms and distribution models that improve access to therapies. The possibilities are nearly limitless.

132
132
article thumbnail

Regeneron and CytomX partner to develop bispecific cancer therapies

Pharmaceutical Technology

This collaboration will use Regeneron’s Veloci-Bi bispecific antibody development platform and CytomX's Probody therapeutic platform. Furthermore, Regeneron will fund preclinical and clinical development and activities related to the commercialisation of the products.

52
article thumbnail

ODAIA wins $25m funding to boost commercial insights platform for pharma

Pharmaceutical Technology

ODAIA will use the latest investment to further advance its artificial intelligence (AI)-powered product offerings, allowing the pharma companies to deliver various life changing therapies to the patients faster.